Announcements!!! 100% APC waiver till March 31, 2023.
Dear Friends,
We are currently accepting manuscripts for its next issue i.e. to be published on June 1, 2023.
Authors can submit their review or research work on or before March 31, 2023 to avail 100% discount on article processing charges.
Thank you
Read more about 100 % APC waiver till March 31, 2023
JPADR Successfully published its Volume 4 Issue 1 on March 1, 2023.
This issue contains one review article, three research articles, two case reports and one conference proceeding of Sree Dattha Institute of Pharmacy, Hyderabad, India.
Thank you
The Journal of Pharmacovigilance and Drug Research (JPADR) is the official publication of the Global Pharmacovigilance Society. This is an international, open access, and peer-reviewed scientific journal. It focuses on pharmacovigilance studies and their associated topics such as adverse drug reaction, drug clinical trials, drug effectiveness and efficacy, drugs risk management, as well as all aspects related to the safe use of drugs.
The JPADR is oriented to researchers, professors, students, and practitioners from both the pharmaceutical industry sector, as well as the wide range of health and medicine arenas. The journal’s objective is to establish a formal platform for communicating the research results on pharmacovigilance.
An official publication of Global Pharmacovigilance Society
“A goal towards patient safety and drug safety”
Abstracting and Indexing: National Digital Library of India, Google Scholar, Geneva foundation for medical education and research, J-Gate, ResearchBib, EuroPub, Zenodo, OpenAIRE, and more.
Contact: editor@jpadr.com/ editor.jpadr@gmail.com
Editor-in-Chief: Dr.Chinmaya Mahapatra, M.Pharm, Ph D.
Login to access subscriber-only resources.
ISSN (online) : 2582-7235
